Search Results
Aug 27, 2026, 08:15 ET Psilera Appoints Neuroscience Veteran Allyson Gage, PhD, as Vice President, Clinical Development to Lead Upcoming Phase 1 Clinical Trial
we advance the neuroplastogen pipeline at Psilera," expressed Magali Haas, MD-PhD, CMO of Psilera. "Allyson brings an exceptional combination of CNS drug development expertise and leadership with her impressive track record navigating the complex path from first-in-human studies through pivotal trials
More news about: Psilera, Inc.
Aug 27, 2026, 07:32 ET African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials
create the drug product – the finished vaccine mixture which combines the drug substance with other vaccine ingredients and packaging ready for testing. In parallel, Minapharm plans to transfer drug substance manufacturing to its biotechnology facilities in Cairo, enabling fully local drug substance and
More news about: Minapharm Pharmaceuticals
Aug 27, 2026, 07:27 ET African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials
create the drug product – the finished vaccine mixture which combines the drug substance with other vaccine ingredients and packaging ready for testing. In parallel, Minapharm plans to transfer drug substance manufacturing to its biotechnology facilities in Cairo, enabling fully local drug substance and
More news about: Minapharm Pharmaceuticals
Aug 27, 2026, 06:30 ET ProFound Therapeutics Receives Investment to Tackle Preeclampsia and Eclampsia
Up to $35 million from the Gates Foundation will support ProFound's use of its platform, datasets, and algorithms to identify new drug targets and biomarkers for preeclampsia and eclampsiaCAMBRIDGE, Mass., Aug.
More news about: ProFound Therapeutics
Aug 27, 2026, 04:03 ET Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
data for Deramiocel. The Company failed to secure the FDA's agreement to this change before it resubmitted a Biologics License Application for the drug. Based on these facts, Capricor's public statements were false and materially misleading throughout the class period.If you are a shareholder
More news about: DJS Law Group LLP
Aug 27, 2026, 02:00 ET TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
arthralgia.USE IN SPECIFIC POPULATIONS There are no available data on TEZSPIRE use in pregnant women to evaluate for any drug-associated risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. Placental transfer of monoclonal antibodies such as
More news about: Amgen
Aug 27, 2026, 02:00 ET AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
inflammatory processes, is thought to be linked to a number of chronic immune-mediated diseases.2 SKYRIZI is approved by the U.S. Food and Drug Administration and the European Medicines Agency for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.2,9EU
More news about: AbbVie
Aug 26, 2026, 23:09 ET Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth
half of 2026. Cumulatively, over 2,557 independent drug targets have been studied, with 212 newly delivered in the first half of 2026. The number of delivered independent drug targets grew markedly, driven by the rapid advancement of AI-powered drug discovery and the resulting surge in wet-lab demand.
More news about: Viva Biotech
Aug 26, 2026, 20:00 ET Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result
compute begins to replace part of a wet-lab process that has depended on repeated library construction, screening and trial and error, the value of AI in drug discovery is also beginning to shift from "predicting more accurately" to "developing more quickly."
More news about: Aureka
Aug 26, 2026, 19:24 ET Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
action.What is this about: On February 13, 2026, the U.S. Food and Drug Administration ("FDA") issued a Complete Response Letter ("CRL") to Disc Medicine regarding its bitopertin program. The FDA stated they could not approve Disc Medicine's new drug application ("NDA") as there were uncertainties in the NDA
More news about: THE ROSEN LAW FIRM, P. A.
Aug 26, 2026, 18:54 ET CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
allegedly failed to disclose that they adopted changes to the pre-specified statistical analysis plan (SAP) without agreement from the U.S. Food and Drug Administration (FDA) prior to resubmitting its Biologics License Application (BLA).The HOPE-3 Trial Breakthrough and
More news about: Hagens Berman Sobol Shapiro LLP
Aug 26, 2026, 17:58 ET Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit
stock price plummeted over 56%. May 14, 2026: Aardvark announced that the U.S. Food and Drug Administration (FDA) placed a full clinical hold on its investigational new drug application (IND) for ARD-101, halting all ongoing studies under the IND, including the Phase 3 HERO trial and
More news about: Hagens Berman Sobol Shapiro LLP
Aug 26, 2026, 17:03 ET In HelloNation, Criminal Defense Attorney Finn Skovdal Discusses What Counts as a Felony in Montgomery County, PA
quickly. Under Pennsylvania law, the severity of a charge depends on intent, harm, value, and prior history. Theft offenses, repeat DUI, and drug distribution are among the most common felony charges in Montgomery County. These charges can develop from situations that may appear minor
More news about: HelloNation
Aug 26, 2026, 16:33 ET Bloomberg 500 (B500) Index Adds Ten Securities Following September Reconstitution
Ltd. and Casey's General Stores will double the representation of the Electronics Manufacturing Services/Original Design Manufacturer and Food & Drug Stores BICS sub-industries, respectively.Thirteen firms will be removed from the index, with removals concentrated primarily in the Consumer
More news about: Bloomberg
Aug 26, 2026, 16:00 ET West to Participate in Upcoming Investor Conferences
Aug. 26, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences:
More news about: West Pharmaceutical Services, Inc.
Aug 26, 2026, 14:52 ET Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
(2024) 100845. [5] Akumaga, T. et al. 2025. Targeting Esophageal Cancer: Promising Drugs for the Clinical Landscape and Key Knowledge Gaps. Drug Design, Development and Therapy 2025:19 12049–12076. [6] Roche. PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody, Package Insert
More news about: Roche
Aug 26, 2026, 12:03 ET Vesselon Issued Patent and New Data Changes the Therapeutic Index of Antibody-Based Drugs
Drug maker delivers 6X more drug to tumor and less to off-target tissues without altering antibody drugsGREENWICH, Conn., Aug. 26, 2026 /PRNewswire/ -- The U.S. Patent and Trademark
More news about: Vesselon Inc.
Aug 26, 2026, 11:38 ET Dove Brings "Hot Seats" to Charli xcx's Music, Fashion, Film Tour, Giving Fans Access to One of the Hottest Music Moments of 2026
alcohol-free as of 2026, and sticks, both designed to deliver all-day, all-over freshness. Dove Whole Body Deo is available nationwide at most mass, food, and drug retailers, MSRP: $12.99.For more information, follow @Dove on social platforms.About Dove: Dove started its life in 1957 in the
More news about: Dove
Aug 26, 2026, 10:57 ET Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth
half of 2026. Cumulatively, over 2,557 independent drug targets have been studied, with 212 newly delivered in the first half of 2026. The number of delivered independent drug targets grew markedly, driven by the rapid advancement of AI-powered drug discovery and the resulting surge in wet-lab demand.
More news about: Viva Biotech
Aug 26, 2026, 10:49 ET Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical
developed for multiple potential indications.About Graviton BioScience CorporationGraviton BioScience Corporation is a clinical-stage drug discovery and development company dedicated to engineering and developing best-in-class therapeutics for treating metabolic, CNS, inflammatory, fibrotic,
More news about: Graviton BioScience Corporation
Aug 26, 2026, 10:41 ET Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
high-risk, BCG-unresponsive NMIBC with carcinoma in situ, with or without Ta or T1 papillary tumors.BioInvent/Transgene's BT-001 is a drug candidate being developed through a collaboration with French biotechnology company Transgene. It is an oncolytic virus engineered to deliver BioInvent's
More news about: DelveInsight Business Research, LLP
Aug 26, 2026, 10:31 ET Congenital Hyperinsulinism Market to Expand at a CAGR of 12% During the Forecast Period (2026-2036) as Rising Disease Recognition and Novel Therapies Fuel Market Growth | DelveInsight
in congenital hyperinsulinism by counteracting hypoglycemia caused by excessive insulin secretion. The drug is currently in the registration stage, with the sponsor planning to resubmit a New Drug Application (NDA) in the second half of 2026.Rezolute's Ersodetug is an investigational monoclonal
More news about: DelveInsight Business Research, LLP
Aug 26, 2026, 10:09 ET AARD DEADLINE: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline
pause and then a full FDA clinical hold on ARD-101, which a securities class action alleges corrected earlier representations that the drug was "99% gut-restricted" with minimal systemic exposure.NEW YORK, Aug.
More news about: Levi & Korsinsky, LLP
Aug 26, 2026, 10:00 ET Qualia Introduces Qualia 2-Day Detox, a First-Of-Its-Kind Total-Body Detox Solution
health, cellular health, NAD+ levels, and the recently released Qualia Stem Cell.*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
More news about: Qualia Life Sciences
Aug 26, 2026, 10:00 ET Opioid Prescribing for Children's Coughs Falls to Just 4 in 10,000 Visits, New Analysis Finds
Food and Drug Administration began issuing warnings, and in 2016, the American Academy of Pediatrics (AAP) responded with its report, "
More news about: Motive Medical Intelligence